Dr. Karen Christine Baker, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 5704 Fayetteville Rd, Durham, NC 27713 Phone: 919-572-4673 Fax: 919-668-0321 |
Tom Spalding, P.A. Urology Medicare: Not Enrolled in Medicare Practice Location: 205 Frasier St, Triangle Urology Associates, P.a., Durham, NC 27704 Phone: 919-477-7003 Fax: 919-471-2827 |
Dr. Thomas James Polascik, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: Duke Cancer Center 5-1 Urology, Duke Cancer Center, Duke University Medical Center, Durham, NC 27710 Phone: 919-684-4946 Fax: 919-684-5220 |
Brant A Inman, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1000 Trent Dr, Durham, NC 27710 Phone: 919-684-8111 |
Dr. Andrew Charles Peterson, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 40 Duke Medicine Cir, Durham, NC 27710 Phone: 919-684-2516 |
Judd Moul, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2100 Erwin Rd, Durham, NC 27710 Phone: 919-620-4467 |
Daniel George, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: Duke University Medical Ctr, Durham, NC 27710 Phone: 919-620-4467 |
Sean Anthony Pierre, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 4101 N Roxboro St, Durham, NC 27704 Phone: 919-684-8111 |
Dr. Thomas Andrew Longo, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2301 Erwin Rd, Ste. 2600, Durham, NC 27705 Phone: 919-684-5537 Fax: 919-681-8521 |
Mimi Wei Zhang, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 205 Frasier St, Durham, NC 27704 Phone: 919-477-7003 Fax: 919-471-2827 |
Dr. Jonathan C Routh, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 40 Duke Medicine Cir, Durham, NC 27710 Phone: 919-684-8111 |
Cary Zakrzewski, Urology Medicare: Not Enrolled in Medicare Practice Location: 2100 Erwin Rd, Durham, NC 27710 Phone: 919-620-4467 |
Deborah Rebecca Kaye, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 20 Duke Medicine Cir, Durham, NC 27710 Phone: 919-684-8111 |
Mr. Robert W Andrews, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 205 Frasier St, Durham, NC 27704 Phone: 919-477-7003 Fax: 919-471-2827 |
Glenn M Preminger, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2100 Erwin Road, Durham, NC 27710 Phone: 919-620-4467 |
Dr. Michael J Andrews Jr., MD Urology Medicare: Not Enrolled in Medicare Practice Location: 4101 N Roxboro St, Durham, NC 27704 Phone: 919-684-8111 |
George Webster, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 2100 Erwin Rd, Durham, NC 27710 Phone: 919-620-4467 |
Dr. John Patrick Selph, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2301 Erwin Rd., Duke University Hospital Division Of Urology, Durham, NC 27710 Phone: 919-684-2516 |
Mr. Niall J Buckley, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 205 Frasier St, Durham, NC 27704 Phone: 919-477-7003 Fax: 919-471-2827 |
John Samuel Wiener, MD Urology Medicare: Accepting Medicare Assignments Practice Location: Erwin Road, Durham, NC 27710 Phone: 919-684-6994 Fax: 919-681-5507 |
News Archive
ForteBio®, Inc., a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, today announced the launch of its new Octet QK(e) instrumentation system. The new system, the next generation of the company's initial eight-channel Octet QK instrument, provides significantly increased sensitivity, enabling analysis of small proteins and peptides. Additionally, the Octet QK(e) system enables biosensors to be re-racked, for increased workflow flexibility and cost savings.
"For the third time in the past decade, drought has returned to the arid, western shoulder of Africa, bringing hunger to millions," and "aid agencies are warning that if action is not taken now, the region known as the Sahel could slip into crisis," the Associated Press reports.
Zalicus Inc. a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases today announced the successful completion of a Phase 1 clinical trial evaluating the pharmacokinetics and safety of a new formulation of Z160, a novel oral N-type calcium channel blocker.
Patients with HER2-positive breast cancer, a particularly aggressive form of breast cancer, now have a new, effective and less toxic therapeutic option.
Exercising to improve our cardiovascular strength may protect us from cognitive impairment as we age, according to a new study by researchers at the University of Montreal and its affiliated Institut universitaire de gératrie de Montréal Research Centre.
› Verified 5 days ago